Think Research Third Quarter 2023 Earnings: EPS Beats Expectations, Revenues Lag

Think Research (CVE:THNK) Third Quarter 2023 Results

Key Financial Results

• Revenue: CA$19.2m (up 4.5% from 3Q 2022).
• Net loss: CA$3.81m (loss narrowed by 41% from 3Q 2022).
• CA$0.049 loss per share (improved from CA$0.11 loss in 3Q 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Think Research EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 13%. Earnings per share (EPS) exceeded analyst estimates by 17%.

Looking ahead, revenue is forecast to grow 7.4% p.a. on average during the next 2 years, compared to a 10% growth forecast for the Healthcare Services industry in North America.

Performance of the market in Canada.

The company's shares are down 17% from a week ago.

Risk Analysis

It's still necessary to consider the ever-present spectre of investment risk. We've identified 3 warning signs with Think Research, and understanding these should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.